Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

North America Neurorehabilitation Device Market Forecast 2021-2028

Published by Inkwood Research Product code 980917
Published Content info 154 Pages
Delivery time: 2-3 business days
Price
Back to Top
North America Neurorehabilitation Device Market Forecast 2021-2028
Published: January 11, 2021 Content info: 154 Pages
Description

KEY FINDINGS

The North America neurorehabilitation device market is registered to grow with a CAGR of 14.35%, over the forecast years of 2021 to 2028. The growing geriatric populace, the investments made for preventing and diagnosing neurogenerative ailments, the increased incidence of neurological conditions, and the rising federal governments' funding.

MARKET INSIGHTS

The North America neurorehabilitation device market is evaluated by assessing the United States and Canada. In Canada, the neurorehabilitation market is propelled by the investments designated for the diagnosis and prevention of neurodegenerative diseases, and the initiatives undertaken by the country's senate. Canada's government continually funds research associated with dementia, annually, as well. According to the Alzheimer Society Canada, the number of Canadians affected by dementia is increasing at a constant pace, considering the country's female and male population.

Similarly, 564,000 citizens lived with dementia in 2020, and this figure is anticipated to increase by 66%, by 2031. As per Dementia in Canada, the Canada Senate adopted the order of reference in 2016, providing authority to the Standing Senate Committee on social affairs. This was essentially done in order to examine and report the incidence of dementia in Canada.

The Alzheimer Society Canada also states that the country's government spends nearly $41 million through the Canadian Institutes of Health Research (CIHR) each year. The expenditure on research operation aims at innovating and developing Alzheimer's therapeutics, as well as diagnosis, in addition to the research investments. This aspect largely enhances awareness, in terms of neurodegenerative diseases. Therefore, such factors are expected to reinforce the neurorehabilitation device market growth in Canada, during the forecast period.

COMPETITIVE INSIGHTS

Some of the leading companies operating in the market are, Ekso Bionics Holdings Inc, Abbott Laboratories, Bionik Laboratories Corp, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 17579

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. GROWING ELDERLY POPULACE
    • 3.1.2. GROWING NEUROREHABILITATION WEARABLES AND ROBOTICS
    • 3.1.3. SIGNIFICANT RISE IN NEUROLOGICAL DISEASES
    • 3.1.4. TECHNOLOGICAL ADVANCEMENTS
  • 3.2. KEY RESTRAINTS
    • 3.2.1. HIGH COST OF TREATMENT
    • 3.2.2. STRINGENT REGULATIONS

4. KEY ANALYTICALS

  • 4.1. PORTER'S FIVE FORCES ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRANTS
    • 4.1.2. THREAT OF SUBSTITUTES
    • 4.1.3. BARGAINING POWER OF BUYER
    • 4.1.4. BARGAINING POWER OF SUPPLIER
    • 4.1.5. INTENSITY OF COMPETITIVE RIVALRY
  • 4.2. IMPACT OF COVID-19 ON NEUROREHABILITATION DEVICE MARKET
  • 4.3. SUPPLY CHAIN ANALYSIS
  • 4.4. TIMELINE OF NEUROREHABILITATION DEVICE
  • 4.5. KEY BUYING CRITERIA
  • 4.6. OPPORTUNITY MATRIX
  • 4.7. VENDOR LANDSCAPE
  • 4.8. KEY INVESTMENT INSIGHTS

5. MARKET BY PRODUCT

  • 5.1. NEURO-ROBOTIC SYSTEM
  • 5.2. BRAIN COMPUTER INTERFACE
  • 5.3. WEARABLE DEVICE
  • 5.4. NON-INVASIVE STIMULATOR
  • 5.5. OTHER PRODUCTS

6. MARKET BY APPLICATION

  • 6.1. STROKE
  • 6.2. CEREBRAL PALSY
  • 6.3. PARKINSON'S DISEASE
  • 6.4. MULTIPLE SCLEROSIS
  • 6.5. OTHER APPLICATIONS

7. MARKET BY END-USER

  • 7.1. HOSPITAL/CLINIC
  • 7.2. RESEARCH INSTITUTE
  • 7.3. COGNITIVE CARE CENTER
  • 7.4. OTHER END-USERS

8. GEOGRAPHICAL ANALYSIS

  • 8.1. NORTH AMERICA
    • 8.1.1. MARKET SIZE & ESTIMATES
    • 8.1.2. KEY GROWTH ENABLERS
    • 8.1.3. KEY CHALLENGES
    • 8.1.4. KEY PLAYERS
    • 8.1.5. COUNTRY ANALYSIS
      • 8.1.5.1. UNITED STATES
      • 8.1.5.2. CANADA

9. COMPETITIVE LANDSCAPE

  • 9.1. KEY STRATEGIC DEVELOPMENTS
    • 9.1.1. MERGER & ACQUISITIONS
    • 9.1.2. PRODUCT LAUNCH & DEVELOPMENTS
    • 9.1.3. PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION
    • 9.1.4. BUSINESS EXPANSION/ APPROVAL/ ANNOUNCEMENT
  • 9.2. COMPANY PROFILES
    • 9.2.1. ABBOTT LABORATORIES
    • 9.2.2. BIOMETRICS LTD
    • 9.2.3. BIONIK LABORATORIES CORP
    • 9.2.4. BIOXTREME
    • 9.2.5. ECTRON LIMITED
    • 9.2.6. EKSO BIONICS HOLDINGS INC
    • 9.2.7. HELIUS MEDICAL TECHNOLOGIES
    • 9.2.8. HOCOMA AG
    • 9.2.9. KINESTICA
    • 9.2.10. KINOVA
    • 9.2.11. MEDTRONIC INC
    • 9.2.12. NEUROSTYLE PTE LTD
    • 9.2.13. TYROMOTION GMBH

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - NEUROREHABILITATION DEVICE
  • TABLE 2: NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 ($ MILLION)
  • TABLE 3: NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 ($ MILLION)
  • TABLE 4: NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 ($ MILLION)
  • TABLE 5: NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 ($ MILLION)
  • TABLE 6: NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 ($ MILLION)
  • TABLE 7: NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY END-USER, FORECAST YEARS, 2021-2028 ($ MILLION)
  • TABLE 8: NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 9: NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 10: LEADING PLAYERS OPERATING IN NORTH AMERICA NEUROREHABILITATION DEVICE MARKET

LIST OF FIGURES:

  • FIGURE 1: PREVALENCE OF ALZHEIMER'S DISEASE IN THE UNITED STATES, AGE WISE, 2019 (%)
  • FIGURE 2: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 3: TIMELINE OF NEUROREHABILITATION DEVICE MARKET
  • FIGURE 4: OPPORTUNITY MATRIX
  • FIGURE 5: VENDOR LANDSCAPE
  • FIGURE 6: KEY INVESTMENT INSIGHTS
  • FIGURE 7: NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY PRODUCT, IN 2020
  • FIGURE 8: NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY NEURO-ROBOTIC SYSTEM, 2021-2028 ($ MILLION)
  • FIGURE 9: NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY BRAIN COMPUTER INTERFACE, 2021-2028 ($ MILLION)
  • FIGURE 10: NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY WEARABLE DEVICE, 2021-2028 ($ MILLION)
  • FIGURE 11: NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY NON-INVASIVE STIMULATOR, 2021-2028 ($ MILLION)
  • FIGURE 12: NORTH AMERICA NEUROREHABILITATION DEVICE MARKET BY, OTHER PRODUCTS, 2021-2028 ($ MILLION)
  • FIGURE 13: NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY APPLICATION, IN 2020
  • FIGURE 14: NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY STROKE, 2021-2028 ($ MILLION)
  • FIGURE 15: NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY CEREBRAL PALSY, 2021-2028 ($ MILLION)
  • FIGURE 16: NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY PARKINSON'S DISEASE, 2021-2028 ($ MILLION)
  • FIGURE 17: NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY MULTIPLE SCLEROSIS, 2021-2028 ($ MILLION)
  • FIGURE 18: NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY OTHER APPLICATIONS, 2021-2028 ($ MILLION)
  • FIGURE 19: NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY END-USER, IN 2020
  • FIGURE 20: NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY HOSPITAL/CLINIC, 2021-2028 ($ MILLION)
  • FIGURE 21: NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY RESEARCH INSTITUTE, 2021-2028 ($ MILLION)
  • FIGURE 22: NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY COGNITIVE CARE CENTER, 2021-2028 ($ MILLION)
  • FIGURE 23: NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY OTHER END-USERS, 2021-2028 ($ MILLION)
  • FIGURE 24: NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 25: UNITED STATES NEUROREHABILITATION DEVICE MARKET, 2021-2028 ($ MILLION)
  • FIGURE 26: CANADA NEUROREHABILITATION DEVICE MARKET, 2021-2028 ($ MILLION)
Back to Top